Egetis Therapeutics

Declaration of Voting Results & Voting Rights Announcements • Nov 23, 2020

Issuer Egetis Therapeutics AB (publ)

Holder

Skandinaviska Enskilda Banken AB

Instrument

Instrument	Common stocks SE0003815604
Before the transaction
Shares	2,908,555
Voting rights	2,908,555
Transaction
Date	20/11/2020
Limit for number of shares 5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	9,517,589
Directly held voting rights 0

Indirectly held voting rights 9,517,589 Percentage Directly held shares 8.11343 %

Directly held voting rights 0 % Indirectly held voting rights 8.11343 %

Resulting distribution of total

holdings

Shares			Percentage of voting rights:	Number of underlying shares:
			8.11343 %	9,517,589
paragraph, line 2	Instruments - FITA Ch. 4, section 2, first
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total			8.11343 %	9,517,589
Chain of controlling companies
Voting rights % Voting rights Company
181,740	0.15493	Gamla Livförsäkringsaktiebolaget SEB Trygg Liv
9,335,849 7.9585		SEB Life International Assurance Company Ltd
0 0 Skandinaviska Enskilda Banken AB
Group total holdings
Voting rights		9,517,589

Percentage of voting rights 8.11343

Published

23/11/2020 14:26

Contact

Name Inga Brutane Phone +46 8 522 296 10 Email GroupComplianceControlRoom@seb.se

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25